Dare Bioscience, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Dare Bioscience, Inc. (DARE) had Common Stock, Capital Shares Reserved for Future Issuance of 3.22 million shares as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-03-26
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 3.22M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 2.62M shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 31.20M shares.
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 17.57M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2025-12-31 | 3.22M shares 10-K · filed 2026-03-26 | |
| 2024-12-31 | 2.62M shares 10-K · filed 2025-03-31 | |
| 2023-12-31 | 31.20M shares 10-K · filed 2024-03-28 | |
| 2022-12-31 | 17.57M shares 10-K · filed 2023-03-30 | |
| 2022-03-31 | 27.00M shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 6.30M shares 10-K · filed 2022-03-31 | |
| 2020-12-31 | 5.20M shares 10-K · filed 2021-03-30 | |
| 2019-12-31 | 6.27M shares 10-K · filed 2020-03-27 | |
| 2018-12-31 | 5.81M shares 10-K · filed 2019-04-01 | |
| 2017-12-31 | 616.88K shares 10-K · filed 2019-04-01 | |
| 2016-12-31 | 120.81K shares 10-K · filed 2018-03-28 | 4.39M shares 10-K · filed 2017-03-31 |
| 2015-12-31 | 4.30M shares 10-K/A · filed 2017-06-13 | |
| 2014-12-31 | 3.69M shares 10-K · filed 2016-03-10 | |
| 2013-12-31 | 8.16M shares 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |